NLRP1 polymorphisms in patients with asbestos-associated mesothelioma

Infectious Agents and Cancer

Volumn 7, Issue 1, 2012, Pages

  Girardelli, Martina ^a   Maestri, Iva ^b   Rinaldi, Rosa R ^c   Tognon, Mauro ^b   Boldorini, Renzo ^d   Bovenzi, Massimo ^a   Crovella, Sergio ^a   Comar, Manola ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Asbestos; Inflammasome; Mesothelioma; NLRP1; NLRP3

Indexed keywords

ASBESTOS;

AGED; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENDEMIC DISEASE; EXPOSURE; FEMALE; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; NLRP1 GENE; NLRP3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85040956314     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-7-25     Document Type: Article

References (33)

1. Yang H, Testa JR, Carbone M: Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol 2008, 9(2-3):147-157.
2. Goodman JE, Nascarella MA, Valberg PA: Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Contro. 2009, 20:1237-1254.
3. Weiner SJ, Neragi-Miandoab S: Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J Cancer Res Clin Oncol 2009, 135:15-27.
4. Dogan AU, Baris Y, Dogan M, Emri S, Steele I, Elmishad AG: Genetic predisposition to fiber carcinogenesis causes a mesotheliom epidemic in turkey. Cancer Res 2006, 66:5063-5068.
5. Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, Collette C, Baba N, Libioulle C, Belaiche J, Bitton A, Gaudet D, Cohen A, Langelier D, Fortin PR, Wither JE, Sarfati M, Rutgeerts P, Rioux JD, Vermeire S, Hudson TJ, Franchimont D: Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 2009, 41(1):71-76.
6. Pontillo A, Brandao L, Guimaraes R, Segat L, Araujo J, Crovella S: Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil. Autoimmunity 2010, 43(8):583-589.
7. Qi F, Carbone M, Yang H, Gaudino G: Simian virus 40 transformation, malignant mesothelioma and brain tumors. Expert Rev Respir Med 2011, 5(5):683-697.
8. Robinson C, Van Bruggen I, Segal A, Dunham M, Sherwood A, Koentgen F, Robinson BW, Lake RA: A novel SV40 Tag transgenic model of asbestosinduced mesothelioma: malignant transformation is dose dependent. Cancer Res 2006, 15:10786-10794.
9. Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, Tosolini A, Grobelny JV, Jhanwar SC, Pass HI, Testa JR, Carbone M: SV40 infectious induces telomerase activity in human mesothelial cells. Oncogene 2002, 21:1434-1442.
10. Pontillo A, Brandão LA, Guimarães RL, Segat L, Athanasakis E, Crovella S: A 3'UTR SNP in NLRP3 gene is associated with susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 2010, 54(3):236-240.
11. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA: NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007, 356(12):1216-1225.
12. Magitta NF, Bøe Wolff AS, Johansson S, Skinningsrud B, Lie BA, Myhr KM, Undlien DE, Joner G, Njølstad PR, Kvien TK, Førre, Knappskog PM, Husebye ES: A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun 2009, 10(2):120-124.
13. Pontillo A, Catamo E, Arosio B, Mari D, Crovella S: NALP1/NLRP1 Genetic variants are associated with Alzheimer disease. Alzheimer Dis Assoc Disord 2011, 26(3):277-281.
14. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J: Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 2007, 55(5):443-452.
15. Comar M, Zanotta N, Pesel G, Visconti P, Maestri I, Rinaldi R, Crovella S, Cortale M, De Zotti R: Bovenzi M Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy. Tumori 2012, 98(2):210-214.
16. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly- Maitre B, Li X, Osterman A, Matsuzawa S, Terskikh AV, Faustin B, Reed JC: Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129(1):45-56.
17. Wang Y, Faux SP, Hallden G, Kirn DH, Houghton CE, Lemoine NR, Patrick G: Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite.ù. Int J Oncol 2004, 25(1):173-178.
18. Krelin Y, Voronov E, Dotan S, Elkabets M, Reich E, Fogel M, Huszar M, Iwakura Y, Segal S, Dinarello CA, Apte RN: Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res 2007, 67(3):1062-1071.
19. Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320(5876):674-677.
20. Verma D, Lerm M, Blomgran Julinder R, Eriksson P, Söderkvist P, Särndahl E: Gene polymorphisms in the NLRP3 inflammasome Are associated with interleukin-1 production and severe inflammation. Arthritis Rheum 2008, 58(3):888-894.
21. Kastbom A, Johansson M, Verma D, Söderkvist P, Rantapää-Dahlqvist S: The CARD8 p.C10X polymorphism associates with the inflammatory activity in early rheumatoid arthritis. Ann Rheum Dis 2009, 69(4):723-726.
22. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Génin P, Civas A, Ryffel B, Kanellopoulos J, Tschopp J, André F, Lidereau R, McLaughlin NM, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L: Activation of the NLRP3 inflammasome in dendritic cells induces IL-1betadependent adaptive immunity against tumors. Nat Med 2009, 15(10):1170-1178.
23. Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, Gazdar AF, Pass HI, Yang H: Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 2012, 227(1):44-58.
24. Carbone M, Yang H: Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res 2012, 18(3):598-604.
25. Okamoto M, Liu W, Luo Y, Tanaka A, Cai X, Norris DA, Dinarello CA, Fujita M: Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin- 1beta. J Biol Chem 2010, 285(9):6477-6488.
26. Aymeric L, Apetoh L, Ghiringhelli F, Tesniere A, Martins I, Kroemer G, Smyth MJ, Zitvogel L: Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res 2010, 70(3):855-858.
27. Ostrand-Rosenberg S, Sinha P: Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009, 182(8):4499-4506.
28. Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow? Lancet 2001, 357(9255):539-545.
29. Balkwill F, Coussens LM: Cancer: an inflammatory link. Nature 2004, 431(7007):405-406.
30. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y: The new world health organization classification of lung tumours. Eur Respir J 2001, 18(6):1059-1068.
31. Cox DG, Canzian F: Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis. Bioinformatics 2001, 17:738-739.
32. Barrett JC, Fry B, Maller J, et al: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
33. Lewis CM: Genetic association studies: design, analysis and interpretation. Brief Bioinform 2002, 3:146-153.